{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:27:32Z","timestamp":1777674452555,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM130447"],"award-info":[{"award-number":["P20GM130447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74775-w","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T14:01:33Z","timestamp":1728655293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pink1\/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats"],"prefix":"10.1038","volume":"14","author":[{"given":"Jane E.","family":"Manganaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin G.","family":"Lamberty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"Stauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"74775_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet. 386, 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"74775_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0972-2327.83083","volume":"14","author":"M Behari","year":"2011","unstructured":"Behari, M. et al. Parkinson\u2019s disease. Ann. Indian Acad. Neurol. 14, 2\u20136. https:\/\/doi.org\/10.4103\/0972-2327.83083 (2011).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"74775_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove, J. & Perier, C. Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience. 211, 51\u201376. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.057 (2012).","journal-title":"Neuroscience"},{"key":"74775_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner, C. M. et al. Rotenone, paraquat, and Parkinson\u2019s disease. Environ. Health Perspect. 119, 866\u2013872. https:\/\/doi.org\/10.1289\/ehp.1002839 (2011).","journal-title":"Environ. Health Perspect."},{"key":"74775_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0014-4886(69)90081-8","volume":"23","author":"RL Faull","year":"1969","unstructured":"Faull, R. L. & Laverty, R. Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp. Neurol. 23, 332\u2013340. https:\/\/doi.org\/10.1016\/0014-4886(69)90081-8 (1969).","journal-title":"Exp. Neurol."},{"key":"74775_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","volume":"222","author":"TH Hsieh","year":"2011","unstructured":"Hsieh, T. H., Chen, J. J., Chen, L. H., Chiang, P. T. & Lee, H. Y. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behav. Brain Res. 222, 1\u20139. https:\/\/doi.org\/10.1016\/j.bbr.2011.03.031 (2011).","journal-title":"Behav. Brain Res."},{"key":"74775_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron. 85, 257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007 (2015).","journal-title":"Neuron"},{"key":"74775_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","volume":"66","author":"TM Dawson","year":"2010","unstructured":"Dawson, T. M., Ko, H. S. & Dawson, V. L. Genetic animal models of Parkinson\u2019s disease. Neuron. 66, 646\u2013661. https:\/\/doi.org\/10.1016\/j.neuron.2010.04.034 (2010).","journal-title":"Neuron"},{"key":"74775_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/embj.201385902","volume":"33","author":"GL McLelland","year":"2014","unstructured":"McLelland, G. L., Soubannier, V., Chen, C. X., McBride, H. M. & Fon, E. A. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33, 282\u2013295. https:\/\/doi.org\/10.1002\/embj.201385902 (2014).","journal-title":"EMBO J."},{"key":"74775_CR10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1083\/jcb.201007013","volume":"191","author":"A Tanaka","year":"2010","unstructured":"Tanaka, A. et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell. Biol. 191, 1367\u20131380. https:\/\/doi.org\/10.1083\/jcb.201007013 (2010).","journal-title":"J. Cell. Biol."},{"key":"74775_CR11","doi-asserted-by":"publisher","first-page":"16697","DOI":"10.1074\/jbc.M117.787739","volume":"292","author":"B Xiao","year":"2017","unstructured":"Xiao, B. et al. Reactive oxygen species trigger Parkin\/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin. J. Biol. Chem. 292, 16697\u201316708. https:\/\/doi.org\/10.1074\/jbc.M117.787739 (2017).","journal-title":"J. Biol. Chem."},{"key":"74775_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell. Biol. 183, 795\u2013803. https:\/\/doi.org\/10.1083\/jcb.200809125 (2008).","journal-title":"J. Cell. Biol."},{"key":"74775_CR13","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298. https:\/\/doi.org\/10.1371\/journal.pbio.1000298 (2010).","journal-title":"PLoS Biol."},{"key":"74775_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey, M. G. & Romero-Ramos, M. Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur. J. Neurosci. 49, 364\u2013383. https:\/\/doi.org\/10.1111\/ejn.14290 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"74775_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JPD-130250","volume":"3","author":"GT Kannarkat","year":"2013","unstructured":"Kannarkat, G. T., Boss, J. M. & Tansey, M. G. The role of innate and adaptive immunity in Parkinson\u2019s disease. J. Parkinsons Dis. 3, 493\u2013514. https:\/\/doi.org\/10.3233\/JPD-130250 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"74775_CR16","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2174\/0929867325666181009161048","volume":"26","author":"N Kustrimovic","year":"2019","unstructured":"Kustrimovic, N., Marino, F. & Cosentino, M. Peripheral immunity, Immunoaging and Neuroinflammation in Parkinson\u2019s Disease. Curr. Med. Chem. 26, 3719\u20133753. https:\/\/doi.org\/10.2174\/0929867325666181009161048 (2019).","journal-title":"Curr. Med. Chem."},{"key":"74775_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","volume":"70","author":"KD Dave","year":"2014","unstructured":"Dave, K. D. et al. Phenotypic characterization of recessive gene knockout rat models of Parkinson\u2019s disease. Neurobiol. Dis. 70, 190\u2013203. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.009 (2014).","journal-title":"Neurobiol. Dis."},{"key":"74775_CR18","doi-asserted-by":"publisher","first-page":"fcz016","DOI":"10.1093\/braincomms\/fcz016","volume":"1","author":"R de Haas","year":"2019","unstructured":"de Haas, R. et al. To be or not to be pink(1): contradictory findings in an animal model for Parkinson\u2019s disease. Brain Commun. 1, fcz016. https:\/\/doi.org\/10.1093\/braincomms\/fcz016 (2019).","journal-title":"Brain Commun."},{"key":"74775_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/jnr.23625","volume":"93","author":"LM Grant","year":"2015","unstructured":"Grant, L. M. et al. Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson\u2019s disease. J. Neurosci. Res. 93, 1713\u20131727. https:\/\/doi.org\/10.1002\/jnr.23625 (2015).","journal-title":"J. Neurosci. Res."},{"key":"74775_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuroscience.2019.04.033","volume":"409","author":"RB Creed","year":"2019","unstructured":"Creed, R. B. et al. Basal and evoked neurotransmitter levels in Parkin, DJ-1, PINK1 and LRRK2 knockout rat striatum. Neuroscience. 409, 169\u2013179. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.04.033 (2019).","journal-title":"Neuroscience"},{"key":"74775_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12035-014-8927-y","volume":"53","author":"LM Villeneuve","year":"2016","unstructured":"Villeneuve, L. M., Purnell, P. R., Boska, M. D. & Fox, H. S. Early expression of Parkinson\u2019s Disease-related mitochondrial abnormalities in PINK1 knockout rats. Mol. Neurobiol. 53, 171\u2013186. https:\/\/doi.org\/10.1007\/s12035-014-8927-y (2016).","journal-title":"Mol. Neurobiol."},{"key":"74775_CR22","doi-asserted-by":"publisher","first-page":"113575","DOI":"10.1016\/j.bbr.2021.113575","volume":"417","author":"VM DeAngelo","year":"2022","unstructured":"DeAngelo, V. M., Hilliard, J. D. & McConnell, G. C. Dopaminergic but not cholinergic neurodegeneration is correlated with gait disturbances in PINK1 knockout rats. Behav. Brain Res. 417, 113575. https:\/\/doi.org\/10.1016\/j.bbr.2021.113575 (2022).","journal-title":"Behav. Brain Res."},{"key":"74775_CR23","doi-asserted-by":"publisher","first-page":"fcab077","DOI":"10.1093\/braincomms\/fcab077","volume":"3","author":"CA Kelm-Nelson","year":"2021","unstructured":"Kelm-Nelson, C. A. et al. Pink1(-\/-) rats are a useful tool to study early Parkinson disease. Brain Commun. 3, fcab077. https:\/\/doi.org\/10.1093\/braincomms\/fcab077 (2021).","journal-title":"Brain Commun."},{"key":"74775_CR24","doi-asserted-by":"publisher","DOI":"10.3791\/62002","author":"KL Stauch","year":"2021","unstructured":"Stauch, K. L. et al. Applying the RatWalker System for Gait Analysis in a genetic rat model of Parkinson\u2019s Disease. J. Vis. Exp. https:\/\/doi.org\/10.3791\/62002 (2021).","journal-title":"J. Vis. Exp."},{"key":"74775_CR25","doi-asserted-by":"publisher","first-page":"100656","DOI":"10.1016\/j.bbih.2023.100656","volume":"31","author":"BG Lamberty","year":"2023","unstructured":"Lamberty, B. G. et al. Parkinson\u2019s disease relevant pathological features are manifested in male Pink1\/Parkin deficient rats. Brain Behav. Immun. Health. 31, 100656. https:\/\/doi.org\/10.1016\/j.bbih.2023.100656 (2023).","journal-title":"Brain Behav. Immun. Health"},{"key":"74775_CR26","doi-asserted-by":"publisher","first-page":"105890","DOI":"10.1016\/j.parkreldis.2023.105890","volume":"116","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Abnormal immune function of B lymphocyte in peripheral blood of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 116, 105890. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105890 (2023).","journal-title":"Parkinsonism Relat. Disord"},{"key":"74775_CR27","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/JPD-223152","volume":"12","author":"E Contaldi","year":"2022","unstructured":"Contaldi, E., Magistrelli, L. & Comi, C. T. Lymphocytes in Parkinson\u2019s Disease. J. Parkinsons Dis. 12, S65\u2013S74. https:\/\/doi.org\/10.3233\/JPD-223152 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"74775_CR28","doi-asserted-by":"publisher","first-page":"e0236966","DOI":"10.1371\/journal.pone.0236966","volume":"15","author":"CK Meikle","year":"2020","unstructured":"Meikle, C. K. et al. Platelet-T cell aggregates in lung cancer patients: implications for thrombosis. PLoS One. 15, e0236966. https:\/\/doi.org\/10.1371\/journal.pone.0236966 (2020).","journal-title":"PLoS One"},{"key":"74775_CR29","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/01616412.2023.2257441","volume":"45","author":"E Afsin","year":"2023","unstructured":"Afsin, E., Cosgun, Z., Kurul, R. & Turkoglu, S. A. The incidence of deep venous thrombosis in Parkinson\u2019s disease. Neurol. Res. 45, 1050\u20131054. https:\/\/doi.org\/10.1080\/01616412.2023.2257441 (2023).","journal-title":"Neurol. Res."},{"key":"74775_CR30","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"33","author":"AM Smith","year":"2018","unstructured":"Smith, A. M. et al. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov. Disord. 33, 1580\u20131590. https:\/\/doi.org\/10.1002\/mds.104 (2018).","journal-title":"Mov. Disord"},{"key":"74775_CR31","doi-asserted-by":"publisher","unstructured":"Schirinzi, T. et al. Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson\u2019s Disease. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231810863 (2022).","DOI":"10.3390\/ijms231810863"},{"key":"74775_CR32","doi-asserted-by":"publisher","unstructured":"Gevezova, M., Kazakova, M., Trenova, A. & Sarafian, V. YKL-40 and the Cellular Metabolic Profile in Parkinson\u2019s Disease. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms242216297 (2023).","DOI":"10.3390\/ijms242216297"},{"key":"74775_CR33","doi-asserted-by":"publisher","first-page":"e0142520","DOI":"10.1371\/journal.pone.0142520","volume":"11","author":"A Barnett-Vanes","year":"2016","unstructured":"Barnett-Vanes, A., Sharrock, A., Birrell, M. A. & Rankin, S. A. Single 9-Colour Flow Cytometric Method to characterise major leukocyte populations in the rat: validation in a model of LPS-Induced Pulmonary inflammation. PLoS One. 11, e0142520. https:\/\/doi.org\/10.1371\/journal.pone.0142520 (2016).","journal-title":"PLoS One"},{"key":"74775_CR34","doi-asserted-by":"publisher","first-page":"9820","DOI":"10.1038\/s41598-020-66745-9","volume":"10","author":"M Grigoruta","year":"2020","unstructured":"Grigoruta, M., Dagda, R. K., Diaz-Sanchez, A. G. & Martinez-Martinez, A. Psychological distress and lack of PINK1 promote bioenergetics alterations in peripheral blood mononuclear cells. Sci. Rep. 10, 9820. https:\/\/doi.org\/10.1038\/s41598-020-66745-9 (2020).","journal-title":"Sci. Rep."},{"key":"74775_CR35","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1083\/jcb.201808118","volume":"217","author":"LE Newman","year":"2018","unstructured":"Newman, L. E. & Shadel, G. S. Pink1\/Parkin link inflammation, mitochondrial stress, and neurodegeneration. J. Cell. Biol. 217, 3327\u20133329. https:\/\/doi.org\/10.1083\/jcb.201808118 (2018).","journal-title":"J. Cell. Biol."},{"key":"74775_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/s0165-5728(00)00422-7","volume":"113","author":"J Bas","year":"2001","unstructured":"Bas, J. et al. Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism. J. Neuroimmunol. 113, 146\u2013152. https:\/\/doi.org\/10.1016\/s0165-5728(00)00422-7 (2001).","journal-title":"J. Neuroimmunol."},{"key":"74775_CR37","doi-asserted-by":"publisher","first-page":"617370","DOI":"10.3389\/fnagi.2021.617370","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Evidence for Peripheral Immune activation in Parkinson\u2019s Disease. Front. Aging Neurosci. 13, 617370. https:\/\/doi.org\/10.3389\/fnagi.2021.617370 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"74775_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","volume":"252","author":"CH Stevens","year":"2012","unstructured":"Stevens, C. H. et al. Reduced T helper and B lymphocytes in Parkinson\u2019s disease. J. Neuroimmunol. 252, 95\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.015 (2012).","journal-title":"J. Neuroimmunol."},{"key":"74775_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1447-0594.2011.00740.x","volume":"12","author":"F Niwa","year":"2012","unstructured":"Niwa, F., Kuriyama, N., Nakagawa, M. & Imanishi, J. Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson\u2019s disease. Geriatr. Gerontol. Int. 12, 102\u2013107. https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00740.x (2012).","journal-title":"Geriatr. Gerontol. Int."},{"key":"74775_CR40","doi-asserted-by":"publisher","unstructured":"Yan, Z. et al. Dysregulation of the adaptive Immune System in patients with early-stage Parkinson Disease. Neurol. Neuroimmunol. Neuroinflamm. 8 https:\/\/doi.org\/10.1212\/NXI.0000000000001036 (2021).","DOI":"10.1212\/NXI.0000000000001036"},{"key":"74775_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.21037\/atm.2019.10.105","volume":"7","author":"C Sun","year":"2019","unstructured":"Sun, C. et al. Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson\u2019s disease. Ann. Transl Med. 7, 637. https:\/\/doi.org\/10.21037\/atm.2019.10.105 (2019).","journal-title":"Ann. Transl Med."},{"key":"74775_CR42","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","volume":"55","author":"NP Rocha","year":"2018","unstructured":"Rocha, N. P. et al. Reduced activated T lymphocytes (CD4\u2009+\u2009CD25+) and plasma levels of cytokines in Parkinson\u2019s Disease. Mol. Neurobiol. 55, 1488\u20131497. https:\/\/doi.org\/10.1007\/s12035-017-0404-y (2018).","journal-title":"Mol. Neurobiol."},{"key":"74775_CR43","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schroder","year":"2018","unstructured":"Schroder, J. B. et al. Immune Cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s Disease. Front. Neurol. 9, 1081. https:\/\/doi.org\/10.3389\/fneur.2018.01081 (2018).","journal-title":"Front. Neurol."},{"key":"74775_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen, L. et al. Peripheral lymphocyte subsets as a marker of Parkinson\u2019s Disease in a Chinese Population. Neurosci. Bull. 33, 493\u2013500. https:\/\/doi.org\/10.1007\/s12264-017-0163-9 (2017).","journal-title":"Neurosci. Bull."},{"key":"74775_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-021-02287-9","volume":"18","author":"A Kouli","year":"2021","unstructured":"Kouli, A. et al. T lymphocyte senescence is attenuated in Parkinson\u2019s disease. J. Neuroinflammation. 18, 228. https:\/\/doi.org\/10.1186\/s12974-021-02287-9 (2021).","journal-title":"J. Neuroinflammation"},{"key":"74775_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K. & Yamada, T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat. Disord. 11, 493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.07.005 (2005).","journal-title":"Parkinsonism Relat. Disord"},{"key":"74775_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson\u2019s disease. Cell. Discov. 7, 52. https:\/\/doi.org\/10.1038\/s41421-021-00280-3 (2021).","journal-title":"Cell. Discov"},{"key":"74775_CR48","doi-asserted-by":"publisher","first-page":"fcad060","DOI":"10.1093\/braincomms\/fcad060","volume":"5","author":"KM Scott","year":"2023","unstructured":"Scott, K. M. et al. B lymphocyte responses in Parkinson\u2019s disease and their possible significance in disease progression. Brain Commun. 5, fcad060. https:\/\/doi.org\/10.1093\/braincomms\/fcad060 (2023).","journal-title":"Brain Commun."},{"key":"74775_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2010.12.001","volume":"233","author":"MA Gruden","year":"2011","unstructured":"Gruden, M. A. et al. Immunoprotection against toxic biomarkers is retained during Parkinson\u2019s disease progression. J. Neuroimmunol. 233, 221\u2013227. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.12.001 (2011).","journal-title":"J. Neuroimmunol."},{"key":"74775_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1750-1326-6-66","volume":"6","author":"M Kedmi","year":"2011","unstructured":"Kedmi, M., Bar-Shira, A., Gurevich, T., Giladi, N. & Orr-Urtreger, A. Decreased expression of B cell related genes in leukocytes of women with Parkinson\u2019s disease. Mol. Neurodegener. 6, 66. https:\/\/doi.org\/10.1186\/1750-1326-6-66 (2011).","journal-title":"Mol. Neurodegener"},{"key":"74775_CR51","doi-asserted-by":"publisher","unstructured":"Li, R. et al. Abnormal B-Cell and tfh-cell profiles in patients with Parkinson Disease: a cross-sectional study. Neurol. Neuroimmunol. Neuroinflamm. 9 https:\/\/doi.org\/10.1212\/NXI.0000000000001125 (2022).","DOI":"10.1212\/NXI.0000000000001125"},{"key":"74775_CR52","doi-asserted-by":"publisher","first-page":"814239","DOI":"10.3389\/fimmu.2022.814239","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang, P. et al. Global characterization of Peripheral B cells in Parkinson\u2019s disease by single-cell RNA and BCR sequencing. Front. Immunol. 13, 814239. https:\/\/doi.org\/10.3389\/fimmu.2022.814239 (2022).","journal-title":"Front. Immunol."},{"key":"74775_CR53","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380\u20131391. https:\/\/doi.org\/10.1038\/s41593-018-0227-9 (2018).","journal-title":"Nat. Neurosci."},{"key":"74775_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou, W. et al. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated alpha-synuclein. Transl Neurodegener. 8, 7. https:\/\/doi.org\/10.1186\/s40035-019-0147-y (2019).","journal-title":"Transl Neurodegener"},{"key":"74775_CR55","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41593-018-0213-2","volume":"21","author":"F Herisson","year":"2018","unstructured":"Herisson, F. et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat. Neurosci. 21, 1209\u20131217. https:\/\/doi.org\/10.1038\/s41593-018-0213-2 (2018).","journal-title":"Nat. Neurosci."},{"key":"74775_CR56","doi-asserted-by":"publisher","unstructured":"Kolabas, Z. I. et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell 186, 3706\u20133725 e3729, doi: (2023). https:\/\/doi.org\/10.1016\/j.cell.2023.07.009","DOI":"10.1016\/j.cell.2023.07.009"},{"issue":"Pt 6","key":"74775_CR57","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/brain\/116.6.1451","volume":"116","author":"R Benecke","year":"1993","unstructured":"Benecke, R., Strumper, P. & Weiss, H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson\u2019s disease but normal in Parkinson-plus syndromes. Brain. 116 (Pt 6), 1451\u20131463. https:\/\/doi.org\/10.1093\/brain\/116.6.1451 (1993).","journal-title":"Brain"},{"key":"74775_CR58","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas, R. H. et al. Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann. Neurol. 37, 714\u2013722. https:\/\/doi.org\/10.1002\/ana.410370604 (1995).","journal-title":"Ann. Neurol."},{"key":"74775_CR59","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00702-010-0446-z","volume":"117","author":"G Sala","year":"2010","unstructured":"Sala, G. et al. Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson\u2019s disease. J. Neural Transm (Vienna). 117, 1093\u20131098. https:\/\/doi.org\/10.1007\/s00702-010-0446-z (2010).","journal-title":"J. Neural Transm (Vienna)"},{"key":"74775_CR60","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s007020050189","volume":"106","author":"C Ferrarese","year":"1999","unstructured":"Ferrarese, C. et al. Reduced platelet glutamate uptake in Parkinson\u2019s disease. J. Neural Transm (Vienna). 106, 685\u2013692. https:\/\/doi.org\/10.1007\/s007020050189 (1999).","journal-title":"J. Neural Transm (Vienna)"},{"key":"74775_CR61","doi-asserted-by":"publisher","unstructured":"Kocer, A. et al. Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson\u2019s disease. Curr. Gerontol. Geriatr. Res. 2013 (986254). https:\/\/doi.org\/10.1155\/2013\/986254 (2013).","DOI":"10.1155\/2013\/986254"},{"key":"74775_CR62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(sici)1096-8652(199907)61:3<216::aid-ajh12>3.0.co;2-b","volume":"61","author":"M Machaczka","year":"1999","unstructured":"Machaczka, M., Rucinska, M., Skotnicki, A. B. & Jurczak, W. Parkinson\u2019s syndrome preceding clinical manifestation of Gaucher\u2019s disease. Am. J. Hematol. 61, 216\u2013217.  (1999).","journal-title":"Am. J. Hematol."},{"key":"74775_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/00207454.2012.751534","volume":"123","author":"M Behari","year":"2013","unstructured":"Behari, M. & Shrivastava, M. Role of platelets in neurodegenerative diseases: a universal pathophysiology. Int. J. Neurosci. 123, 287\u2013299. https:\/\/doi.org\/10.3109\/00207454.2012.751534 (2013).","journal-title":"Int. J. Neurosci."},{"key":"74775_CR64","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1161\/01.str.22.12.1607","volume":"22","author":"P Sharma","year":"1991","unstructured":"Sharma, P., Nag, D., Atam, V., Seth, P. K. & Khanna, V. K. Platelet aggregation in patients with Parkinson\u2019s disease. Stroke. 22, 1607\u20131608. https:\/\/doi.org\/10.1161\/01.str.22.12.1607 (1991).","journal-title":"Stroke"},{"key":"74775_CR65","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1038\/s41598-022-12886-y","volume":"12","author":"L Acquasaliente","year":"2022","unstructured":"Acquasaliente, L. et al. Exogenous human alpha-synuclein acts in vitro as a mild platelet antiaggregant inhibiting alpha-thrombin-induced platelet activation. Sci. Rep. 12, 9880. https:\/\/doi.org\/10.1038\/s41598-022-12886-y (2022).","journal-title":"Sci. Rep."},{"key":"74775_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bcmd.2018.09.001","volume":"73","author":"H Tashkandi","year":"2018","unstructured":"Tashkandi, H., Shameli, A., Harding, C. V. & Maitta, R. W. Ultrastructural changes in peripheral blood leukocytes in alpha-synuclein knockout mice. Blood Cells Mol. Dis. 73, 33\u201337. https:\/\/doi.org\/10.1016\/j.bcmd.2018.09.001 (2018).","journal-title":"Blood Cells Mol. Dis."},{"key":"74775_CR67","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11239-021-02607-z","volume":"53","author":"CM Stefaniuk","year":"2022","unstructured":"Stefaniuk, C. M., Schlegelmilch, J., Meyerson, H. J., Harding, C. V. & Maitta, R. W. Initial assessment of alpha-synuclein structure in platelets. J. Thromb. Thrombolysis. 53, 950\u2013953. https:\/\/doi.org\/10.1007\/s11239-021-02607-z (2022).","journal-title":"J. Thromb. Thrombolysis"},{"key":"74775_CR68","first-page":"54","volume":"36","author":"AZ Drozdov","year":"1990","unstructured":"Drozdov, A. Z. & Anokhina, I. P. [Activity of tyrosine hydroxylase and monoamine oxidase in human platelets during alcoholism]. Vopr Med. Khim. 36, 54\u201357 (1990).","journal-title":"Vopr Med. Khim."},{"key":"74775_CR69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.neulet.2006.01.062","volume":"399","author":"P Frankhauser","year":"2006","unstructured":"Frankhauser, P. et al. Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci. Lett. 399, 197\u2013201. https:\/\/doi.org\/10.1016\/j.neulet.2006.01.062 (2006).","journal-title":"Neurosci. Lett."},{"key":"74775_CR70","doi-asserted-by":"publisher","first-page":"14377","DOI":"10.1038\/s41598-018-32716-4","volume":"8","author":"TG Walsh","year":"2018","unstructured":"Walsh, T. G., van den Bosch, M. T. J., Lewis, K. E., Williams, C. M. & Poole, A. W. Loss of the mitochondrial kinase PINK1 does not alter platelet function. Sci. Rep. 8, 14377. https:\/\/doi.org\/10.1038\/s41598-018-32716-4 (2018).","journal-title":"Sci. Rep."},{"key":"74775_CR71","doi-asserted-by":"publisher","unstructured":"Lee, S. H., Du, J., Hwa, J. & Kim, W. H. Parkin Coordinates Platelet Stress Response in diabetes Mellitus: A big role in a small cell. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21165869 (2020).","DOI":"10.3390\/ijms21165869"},{"key":"74775_CR72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1160\/TH14-12-1067","volume":"114","author":"MR Thomas","year":"2015","unstructured":"Thomas, M. R. & Storey, R. F. The role of platelets in inflammation. Thromb. Haemost. 114, 449\u2013458. https:\/\/doi.org\/10.1160\/TH14-12-1067 (2015).","journal-title":"Thromb. Haemost"},{"key":"74775_CR73","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple, J. W., Italiano, J. E. Jr. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264\u2013274. https:\/\/doi.org\/10.1038\/nri2956 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"74775_CR74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","volume":"23","author":"P Blair","year":"2009","unstructured":"Blair, P. & Flaumenhaft, R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 23, 177\u2013189. https:\/\/doi.org\/10.1016\/j.blre.2009.04.001 (2009).","journal-title":"Blood Rev."},{"key":"74775_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpn.2012.08.005","volume":"17","author":"C Goubau","year":"2013","unstructured":"Goubau, C., Buyse, G. M., Di Michele, M., Van Geet, C. & Freson, K. Regulated granule trafficking in platelets and neurons: a common molecular machinery. Eur. J. Paediatr. Neurol. 17, 117\u2013125. https:\/\/doi.org\/10.1016\/j.ejpn.2012.08.005 (2013).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"74775_CR76","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1515\/med-2016-0048","volume":"11","author":"V Pavlovic","year":"2016","unstructured":"Pavlovic, V., Ciric, M., Jovanovic, V. & Stojanovic, P. Platelet Rich plasma: a short overview of certain bioactive components. Open. Med. (Wars). 11, 242\u2013247. https:\/\/doi.org\/10.1515\/med-2016-0048 (2016).","journal-title":"Open. Med. (Wars)"},{"key":"74775_CR77","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz, E. D. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 136, 1330\u20131341. https:\/\/doi.org\/10.1182\/blood.2020007252 (2020).","journal-title":"Blood"},{"key":"74775_CR78","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jid.2019.08.457","volume":"140","author":"MT Sanz-Martinez","year":"2020","unstructured":"Sanz-Martinez, M. T. et al. High levels of platelet-lymphocyte complexes in patients with Psoriasis are Associated with a better response to Anti-TNF-alpha Therapy. J. Investig Dermatol. 140, 1176\u20131183. https:\/\/doi.org\/10.1016\/j.jid.2019.08.457 (2020).","journal-title":"J. Investig Dermatol."},{"key":"74775_CR79","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s11239-015-1212-8","volume":"40","author":"BB Nkambule","year":"2015","unstructured":"Nkambule, B. B., Davison, G. & Ipp, H. Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals. J. Thromb. Thrombolysis. 40, 458\u2013467. https:\/\/doi.org\/10.1007\/s11239-015-1212-8 (2015).","journal-title":"J. Thromb. Thrombolysis"},{"key":"74775_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/cmi.2014.66","volume":"12","author":"H Liang","year":"2015","unstructured":"Liang, H. et al. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Cell. Mol. Immunol. 12, 435\u2013443. https:\/\/doi.org\/10.1038\/cmi.2014.66 (2015).","journal-title":"Cell. Mol. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74775-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:03:13Z","timestamp":1728925393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74775-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74775"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74775-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4431604\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23861"}}